UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.963

Sortiert nach

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2010-05, Vol.21 (suppl-5), p.v59-v64

2010

Volltextzugriff (PDF)

Hepatocellular carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of oncology, 2009-05, Vol.20 (suppl-4), p.iv41-iv45

Jelic, S.

2009

Volltextzugriff (PDF)

Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2010-05, Vol.21 (suppl-5), p.v55-v58

2010

Volltextzugriff (PDF)

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2011-09, Vol.22 (suppl_6), p.vi40-vi44

2011

Volltextzugriff (PDF)

P 7: Does choice of antidiabetic and/or antihypertensive treatment influence progression of nephropathy in hypertensive type 2 diabetic patients?

Diabetes & metabolism, 2012-11, Vol.38, p.S105-S106

Jelic, S

2012

Volltextzugriff (PDF)

Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2010-05, Vol.21 (suppl-5), p.v223-v227

2010

Volltextzugriff (PDF)

Competitive analysis of omega-3 polyunsaturated fatty acid-enriched eggs in the Republic of Croatia

World's poultry science journal, 2024-03, Vol.80 (1), p.251-261

2024

Volltextzugriff (PDF)

Neuroendocrine gastroenteropancreatic tumors: ESMO Clinical Recommendation for diagnosis, treatment and follow-up

Annals of oncology, 2009-05, Vol.20 (suppl-4), p.iv150-iv153

2009

Volltextzugriff (PDF)

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2010-05, Vol.21 (suppl-5), p.v65-v69

2010

Volltextzugriff (PDF)

Neuroendocrine bronchial and thymic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2010-05, Vol.21 (suppl-5), p.v220-v222

2010

Volltextzugriff (PDF)

Comparing ICT With Physical Manipulative Supported Learning of 3D Geometry in Elementary School

Journal of educational computing research, 2022-01, Vol.59 (8), p.1623-1654

2022

Volltextzugriff (PDF)

Pancreatic cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of oncology, 2009-05, Vol.20 (suppl-4), p.iv37-iv40

2009

Volltextzugriff (PDF)

Neuroendocrine bronchial and thymic tumors: ESMO Clinical Recommendation for diagnosis, treatment and follow-up

Annals of oncology, 2009-05, Vol.20 (suppl-4), p.iv147-iv149

2009

Volltextzugriff (PDF)

Neuroendocrine bronchial and thymic tumors: ESMO Clinical Recommendation for diagnosis, treatment and follow-up

Annals of oncology, 2008-05, Vol.19 (suppl-2), p.ii102-ii103

2008

Volltextzugriff (PDF)

Biliary cancer: ESMO Clinical Recommendation for diagnosis, treatment and follow-up

Annals of oncology, 2009-05, Vol.20 (suppl-4), p.iv46-iv48

2009

Volltextzugriff (PDF)

Hepatocellular carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of oncology, 2008-05, Vol.19 (suppl-2), p.ii27-ii28

2008

Volltextzugriff (PDF)

Neuroendocrine gastroenteropancreatic tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of oncology, 2008-05, Vol.19 (suppl-2), p.ii104-ii105

2008

Volltextzugriff (PDF)

Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea

The European respiratory journal, 2009-04, Vol.33 (4), p.793-796

2009

Volltextzugriff (PDF)

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant glioma

Annals of oncology, 2005-05, Vol.16 (suppl-1), p.i64-i65

2005

Volltextzugriff (PDF)

9A.09: PROTECTION AGAINST COMPLEMENT ACTIVITY IS REDUCED IN ARTERIAL HYPERTENSION

Journal of hypertension, 2015-06, Vol.33 Suppl 1 - ESH 2015 Abstract Book (Supplement 1), p.e119-e119

2015

Volltextzugriff (PDF)

Doxorubicin and Paclitaxel Versus Fluorouracil, Doxorubicin, and Cyclophosphamide as First-Line Therapy for Women With Metastatic Breast Cancer: Final Results of a Randomized Phase III Multicenter Trial

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1707-1715

2001

Volltextzugriff (PDF)

133: Oral cavity changes in lymphoma patients

European journal of cancer (1990), 2014-07, Vol.50, p.S30-S30

2014

Volltextzugriff (PDF)

Pancreatic cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of oncology, 2008-05, Vol.19 (suppl-2), p.ii25-ii26

2008

Volltextzugriff (PDF)

Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971 TAX 323)

British journal of cancer, 2010-10, Vol.103 (8), p.1173-1181

2010

Volltextzugriff (PDF)

Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer : the X-ACT trial

British journal of cancer, 2006-04, Vol.94 (8), p.1122-1129

2006

Volltextzugriff (PDF)

1 – 25 von 2.963

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.235)
Mit Volltextzugriff
(2.563)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(48)
... seit 30 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Hepatocellular carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

P 7: Does choice of antidiabetic and/or antihypertensive treatment influence progression of nephropathy in hypertensive type 2 diabetic patients?

Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Competitive analysis of omega-3 polyunsaturated fatty acid-enriched eggs in the Republic of Croatia

Neuroendocrine gastroenteropancreatic tumors: ESMO Clinical Recommendation for diagnosis, treatment and follow-up

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Neuroendocrine bronchial and thymic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Comparing ICT With Physical Manipulative Supported Learning of 3D Geometry in Elementary School

Pancreatic cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Neuroendocrine bronchial and thymic tumors: ESMO Clinical Recommendation for diagnosis, treatment and follow-up

Neuroendocrine bronchial and thymic tumors: ESMO Clinical Recommendation for diagnosis, treatment and follow-up

Biliary cancer: ESMO Clinical Recommendation for diagnosis, treatment and follow-up

Hepatocellular carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Neuroendocrine gastroenteropancreatic tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant glioma

9A.09: PROTECTION AGAINST COMPLEMENT ACTIVITY IS REDUCED IN ARTERIAL HYPERTENSION

Doxorubicin and Paclitaxel Versus Fluorouracil, Doxorubicin, and Cyclophosphamide as First-Line Therapy for Women With Metastatic Breast Cancer: Final Results of a Randomized Phase III Multicenter Trial

133: Oral cavity changes in lymphoma patients

Pancreatic cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971 TAX 323)

Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer : the X-ACT trial

Suchergebnisse filtern